Terms: = Sarcomas AND TAF15, hTAFII68, 8148, ENSG00000172660, TAF2N, RBP56, Npl3, Q92804
77 results:
1. Insights into Molecular Diversity within the FUS/EWS/taf15 Protein Family: Unraveling Phase Separation of the N-Terminal Low-Complexity Domain from RNA-Binding Protein EWS.
Johnson CN; Sojitra KA; Sohn EJ; Moreno-Romero AK; Baudin A; Xu X; Mittal J; Libich DS
J Am Chem Soc; 2024 Mar; 146(12):8071-8085. PubMed ID: 38492239
[TBL] [Abstract] [Full Text] [Related]
2. taf15 amyloid filaments in frontotemporal lobar degeneration.
Tetter S; Arseni D; Murzin AG; Buhidma Y; Peak-Chew SY; Garringer HJ; Newell KL; Vidal R; Apostolova LG; Lashley T; Ghetti B; Ryskeldi-Falcon B
Nature; 2024 Jan; 625(7994):345-351. PubMed ID: 38057661
[TBL] [Abstract] [Full Text] [Related]
3. Frontotemporal lobar degeneration.
Grossman M; Seeley WW; Boxer AL; Hillis AE; Knopman DS; Ljubenov PA; Miller B; Piguet O; Rademakers R; Whitwell JL; Zetterberg H; van Swieten JC
Nat Rev Dis Primers; 2023 Aug; 9(1):40. PubMed ID: 37563165
[TBL] [Abstract] [Full Text] [Related]
4. Extraskeletal myxoid chondrosarcoma: a case report.
Haloui A; Karich N; Aissaoui A; Akouh N; Bekhakh C; Mokhtari O; Abdeljaouad N; Bennani A
Pan Afr Med J; 2023; 44():199. PubMed ID: 37484580
[TBL] [Abstract] [Full Text] [Related]
5. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract] [Full Text] [Related]
6. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of taf15::NR4A3 Fusion.
Huang SC; Lee JC; Hsu YC; Tsai JW; Kao YC; Hsieh TH; Chang YM; Chang KC; Wu PS; Chen PC; Chen CH; Chang CD; Lee PH; Tai HC; Liu TT; Wen MC; Li WS; Yu SC; Wang JC; Huang HY
Mod Pathol; 2023 Jul; 36(7):100161. PubMed ID: 36948401
[TBL] [Abstract] [Full Text] [Related]
7. Keratin-positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour.
Sugino H; Iwata S; Satomi K; Mori T; Nobusawa S; Nagashima T; Matsushita Y; Yatabe Y; Ichimura K; Kawai A; Yoshida A
Histopathology; 2023 May; 82(6):937-945. PubMed ID: 36754860
[TBL] [Abstract] [Full Text] [Related]
8. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.
Lenz J; Klubíčková N; Ptáková N; Hájková V; Grossmann P; Šteiner P; Kinkor Z; Švajdler M; Michal M; Konečná P; Macháčová D; Hurník P; Tichý M; Tichý F; Kyllar M; Fiala L; Kavka M; Michal M
Hum Pathol; 2023 Apr; 134():19-29. PubMed ID: 36563884
[TBL] [Abstract] [Full Text] [Related]
9. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases.
Giner F; López-Guerrero JA; Machado I; Rubio-Martínez LA; Espino M; Navarro S; Agra-Pujol C; Ferrández A; Llombart-Bosch A
Virchows Arch; 2023 Feb; 482(2):407-417. PubMed ID: 36376703
[TBL] [Abstract] [Full Text] [Related]
10. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
[TBL] [Abstract] [Full Text] [Related]
11. Acetylation dependent translocation of EWSR1 regulates CHK2 alternative splicing in response to DNA damage.
Zhang T; Wang Z; Liu M; Liu L; Yang X; Zhang Y; Bie J; Li Y; Ren M; Song C; Wang W; Tan H; Luo J
Oncogene; 2022 Jul; 41(29):3694-3704. PubMed ID: 35732801
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a novel translocation producing an in-frame fusion of taf15 and ETV4 in a case of extraosseous Ewing sarcoma revealed in the prenatal period.
Picard C; Macagno N; Corradini N; Marec-Bérard P; Cabet S; Guibaud L; Viremouneix L; Raux S; Chotel F; Weinbreck N; Meurgey A; Karanian M; Pissaloux D; Tirode F; Dijoud F
Virchows Arch; 2022 Oct; 481(4):665-669. PubMed ID: 35527322
[TBL] [Abstract] [Full Text] [Related]
13. FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.
Lindén M; Vannas C; Österlund T; Andersson L; Osman A; Escobar M; Fagman H; Ståhlberg A; Åman P
Mol Oncol; 2022 Jul; 16(13):2470-2495. PubMed ID: 35182012
[TBL] [Abstract] [Full Text] [Related]
14. The
Johnson CN; Xu X; Holloway SP; Libich DS
Biomol NMR Assign; 2022 Apr; 16(1):67-73. PubMed ID: 34994941
[TBL] [Abstract] [Full Text] [Related]
15. SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.
Wei S; Pei J; von Mehren M; Abraham JA; Patchefsky AS; Cooper HS
Genes Chromosomes Cancer; 2021 Oct; 60(10):709-712. PubMed ID: 34124809
[TBL] [Abstract] [Full Text] [Related]
16. FUS oncofusion protein condensates recruit mSWI/SNF chromatin remodeler via heterotypic interactions between prion-like domains.
Davis RB; Kaur T; Moosa MM; Banerjee PR
Protein Sci; 2021 Jul; 30(7):1454-1466. PubMed ID: 34018649
[TBL] [Abstract] [Full Text] [Related]
17. Loci-specific phase separation of FET fusion oncoproteins promotes gene transcription.
Zuo L; Zhang G; Massett M; Cheng J; Guo Z; Wang L; Gao Y; Li R; Huang X; Li P; Qi Z
Nat Commun; 2021 Mar; 12(1):1491. PubMed ID: 33674598
[TBL] [Abstract] [Full Text] [Related]
18. Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.
Paioli A; Stacchiotti S; Campanacci D; Palmerini E; Frezza AM; Longhi A; Radaelli S; Donati DM; Beltrami G; Bianchi G; Barisella M; Righi A; Benini S; Fiore M; Picci P; Gronchi A
Ann Surg Oncol; 2021 Feb; 28(2):1142-1150. PubMed ID: 32572850
[TBL] [Abstract] [Full Text] [Related]
19. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders.
Panza F; Lozupone M; Seripa D; Daniele A; Watling M; Giannelli G; Imbimbo BP
Nat Rev Neurol; 2020 Apr; 16(4):213-228. PubMed ID: 32203398
[TBL] [Abstract] [Full Text] [Related]
20. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and taf15 translocated extraskeletal myxoid chondrosarcomas.
Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
[TBL] [Abstract] [Full Text] [Related]
[Next]
